Ultrasound may help doctors manage fluids in preeclampsia after spinal anesthesia
NCT ID NCT07514130
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether ultrasound of the lungs and a major vein (vena cava) can accurately measure fluid status in women with mild preeclampsia after they receive spinal anesthesia for delivery. Researchers will compare ultrasound findings to traditional methods in 62 participants. The goal is to see if ultrasound can better guide fluid management and improve outcomes for mothers and babies.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Ultrasound (lung and inferior vena cava imaging)
- What this could lead to
- If successful, this could give doctors a reliable, non-invasive way to guide fluid management after spinal anesthesia in preeclampsia, potentially reducing complications.
- What could go wrong
- This is a very early, small study (62 participants) focused on measurement accuracy, not treatment. Results may not apply to all patients or change outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
62 people
The number who actually took part.
- Started
-
Aug 2024
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 35 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Age 20 to35 years * Gestational age 36 weeks * Body mass index (BMI) \<35kg/m2. * Mild preeclampsia Exclusion criteria : * Age \<19 or \>40 years, gestational age \<36 weeks, body mass index (BMI)≥40kg/m2. * Women presenting in emergency delivery. * Patient with other co morbidity sever cardiovascular or central nervous disease.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Preeclampsia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Menofia University
Shibīn al Kawm, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a fetal heart ultrasound index predict trouble in High-Risk pregnancies?
- A bracelet and a blood pressure cuff: a simple plan to protect new mothers at risk
- Can a Light-Based scan spot preeclampsia before it strikes?
- Can a malaria drug help prevent preeclampsia?
- Which drug best steadies blood pressure during C-Section in preeclampsia?
- Two common drugs face off to shield mothers from a dangerous drop in blood pressure